Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFICIENT: High Dose Clopidogrel in Clopidogrel Resistance
NCT01032668Phase 3Completed
- Sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Start
- Sep 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in coronary artery disease (CAD), sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Started Sep 2008; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01032668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032668.